Director, APAC, Regional Market Access, Immunology

Location: Singapore, Singapore; requires up to 50% travel, including regular country visits across the Asia-Pacific region.

Company

Johnson & Johnson MedTech operates within Johnson & Johnson’s healthcare and Innovative Medicine businesses, developing medicines and healthcare solutions for complex diseases.

What you will do

• Develop and implement regional market access strategies for an inflammatory bowel disease portfolio across different stages of development.
• Shape global pricing, access, and evidence-generation strategies while representing the Asia-Pacific perspective in global forums.
• Build value propositions, access model frameworks, health economic models, evidence, and value messages for country teams.
• Lead launch readiness and collaborate with operating companies to address complex pricing and reimbursement requirements.
• Manage the disease-area market access budget, participate in regional and global business reviews, and advise on investment decisions.
• Develop regional policy positions and engage with external bodies on market access topics.

Requirements

• Bachelor’s degree required; an advanced degree in a market access-related field is highly desirable.
• At least 8 years of progressive market access or pricing experience with a record of cross-functional leadership.
• Deep technical knowledge of market access and payer processes, particularly across Asia-Pacific.
• Experience leading market access for launch products at regional or operating-company level is preferred.
• Experience managing people in matrix organizations and achieving results through other leaders.
• Pharmaceutical experience and the ability to rapidly assimilate sophisticated science and data are preferred.

Nice to have

• Advanced degree in a market access-related field.
• Experience with R&D programs and commercial and evidence-generation strategy.

Culture & Benefits

• Inclusive work environment focused on individual dignity, diversity, and merit.
• Collaboration across global, regional, commercial, medical, pricing, and local operating-company teams.
• Opportunity to influence access to innovative treatments across highly developed, middle-income, and emerging markets.
• Role includes regional travel of up to 50%.